Leave aside the aseptic clause in 211.42, and 21 CFR 211.46 is all US drug GMP regulation says on ventilation: four short paragraphs.
It asks for adequate ventilation; control over air pressure, micro-organisms, dust, humidity and temperature when appropriate; filtered supply air to production areas when appropriate; and separate air handling for penicillin. Section 211.42 adds that aseptic processing needs HEPA-filtered air under positive pressure, temperature and humidity control, and environmental monitoring.
EU GMP Chapter 3 on premises is just as brief on numbers. Production areas should be effectively ventilated, with air control suited to the products and operations, and laid out to limit cross-contamination, with dedicated facilities decided through quality risk management.
Neither text gives an air change rate or a pressure differential, and beyond 211.42's HEPA requirement for aseptic areas neither sets a filter class. For sterile products those come from Annex 1 and FDA's 2004 aseptic processing guidance. For an OSD plant they come from ISO 14644, industry guides and the designer's own justification.
That leaves the argument to the design basis, with each value traced to a standard, a guide or a risk assessment. Humiley's design basis records that source for every HVAC value.
Topics
Industries




